TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
An announcement from Klotho Neurosciences ( (KLTO) ) is now available.
On December 2, 2025, Klotho Neurosciences entered into a Securities Purchase Agreement with Sigma9 Capital, Ltd. The agreement involves the issuance and sale of 3,400 shares of a new class of Series C Preferred Stock at $4,400 per share. Each share is convertible into 10,000 shares of common stock, with restrictions on conversion to prevent exceeding ownership limits and compliance with Nasdaq rules. The transaction was made under an exemption from registration, based on a pre-existing relationship and the investor’s capability to assess investment risks.
More about Klotho Neurosciences
Average Trading Volume: 1,494,724
Technical Sentiment Signal: Sell
Current Market Cap: $36.34M
See more data about KLTO stock on TipRanks’ Stock Analysis page.